Journal
DIABETES & METABOLISM
Volume 36, Issue 6, Pages 476-483Publisher
MASSON EDITEUR
DOI: 10.1016/j.diabet.2010.08.004
Keywords
Type 2 diabetes; Patient profiles; Behaviour; Beliefs; Self-management
Categories
Funding
- Novartis Pharmaceuticals Corporation
- Novartis
- Abbott
- Amgen
- Astra-Zeneca
- Bayer
- Boehringer Ingelheim
- Eli Lilly
- GlaxoSmithKline
- LifeScan
- Merck Sharp Dohme-Chibret
- Novo Nordisk
- Pfizer
- Roche Diagnostics
- Roche Pharma
- Sankyo
- Sanofi Aventis
- Servier
- Takeda
- Therval
- Merck-Lipha
Ask authors/readers for more resources
Aim. - This study evaluated the profiles of patients with type 2 diabetes (T2DM) to identify sets of opinions and attitudes towards the disease that might influence self-care behaviours. Methods. - Altogether, 1,092 patients with T2DM, aged 45 or older from a large representative French cohort, completed a self-questionnaire exploring their knowledge and perceptions of diabetes, its impact on various aspects of daily life and self-management practices. Canonical and cluster analyses were used to identify sets of homogeneous 'profiles' of patients linking attitudes and opinions to specific disease-related behaviours (such as changes in lifestyle, drug compliance, treatment satisfaction, impact on everyday life and weight gain). Results. - Demographics of the T2DM study population were previously reported along with the main results (60% male; mean age: 66 years; mean age at diagnosis: 55 years; mean BMI: 29 kg/m(2)). Five distinct patient types emerged from the typological approach: 'committed' (25%); 'carefree' (23%); 'bitter' (19%); 'disheartened' (19%); and 'overwhelmed' (15%). Each patient type defined a set of attitudes and beliefs towards T2DM that influenced disease-related behaviours, leading to different degrees of diabetes self-management. Conclusion. - The DIABASIS survey provides important information for diabetes care by identifying distinct patients' profiles that express different degrees of difficulty in implementing self-management. For this reason, patients in each category require different kinds of customized support from their physician to induce behavioural changes that may be key in improving their metabolic control. (C) 2010 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available